12:01 JST, June 12, 2025
MONTREAL (Reuters) — Airlines need to reach long-term agreements to buy bigger quantities of sustainable aviation fuel (SAF) if they want to boost global volumes of the lower-emission fuel required for industry climate targets, a Bayer executive said on June 3.
Airline members of the International Air Transport Association (IATA) are sticking to a target of net zero emissions by 2050 despite warnings that carriers will struggle to meet such sustainability goals due to low production of SAF, which is more expensive than conventional jet fuel.
While airlines have called for greater action by energy companies and other partners to boost SAF volumes, Matthias Berninger, a Bayer executive vice president and sustainability head, said in Montreal there needs to be more long-term purchases of the fuel, similar to some commitments in the renewable energy sector.
Bayer, which acquired Monsanto in 2018, said its crop science unit sells seeds and pesticides to farmers who produce crops for biomass-based feedstocks used to develop biofuels.
“If they [airlines] commit to buy a certain amount over a certain period of time, we can guarantee that farmers will grow it and processors will process it,” Berninger said to Reuters.
Top Articles in Science & Nature
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed
-
Record 700 Startups to Gather at SusHi Tech Tokyo in April; Event Will Center on Themes Like Artificial Intelligence and Robotics
-
Parents in Japan to Get Instagram Notifications When Teens Repeatedly Search for Suicide Content
-
iPS Cell Products for Parkinson’s, Heart Disease OK’d for Commercialization by Japan Health Ministry Panel
-
Japan to Ban Use of Power Banks on Airplanes
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Japan Figure Skating Legend Yuzuru Hanyu Is Proud Disaster Survivor and Gold Medalist, Vows to Continue Support Efforts
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

